Complement 5a receptor inhibition improves renal allograft survival

Journal of the American Society of Nephrology

Volumn 19, Issue 12, 2008, Pages 2302-2312

  Gueler, Faikah ^a   Rong, Song ^a   Gwinner, Wilfried ^a   Mengel, Michael ^a,d   Bröcker, Verena ^a   Schön, Sylvia ^a   Greten, Tim Friedrich ^a   Hawlisch, Heiko ^c   Polakowski, Thomas ^c   Schnatbaum, Karsten ^c   Menne, Jan ^a,b   Haller, Hermann ^a   Shushakova, Nelli ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Phenos GmbH   (Germany)

^c Jerini AG   (Germany)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; JPE 1375; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; APOPTOSIS; ARTICLE; CELL ADHESION; CELL INFILTRATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; KIDNEY ALLOGRAFT; KIDNEY CELL; KIDNEY PARENCHYMA; KIDNEY STRUCTURE; KIDNEY TRANSPLANTATION; MACROPHAGE; MALE; MONOCYTE; MOUSE; NICK END LABELING; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SURVIVAL TIME; T LYMPHOCYTE; TUBULOINTERSTITIUM; UPREGULATION;

EID: 57149119305     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2007111267     Document Type: Article

References (58)

1. Haas PJ, van Strijp J: Anaphylatoxins: Their role in bacterial infection and inflammation. Immunol Res 37: 161-175, 2007
2. Gutzmer R, Kother B, Zwirner J, Dijkstra D, Purwar R, Wittmann M, Werfel T: Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a. J Invest Dermatol 126: 2422-2429, 2006
3. Connelly MA, Moulton RA, Smith AK, Lindsey DR, Sinha M, Wetsel RA, Jagannath C: Mycobacteria-primed macrophages and dendritic cells induce an up-regulation of complement C5a anaphylatoxin receptor (CD88) in CD3+ murine T cells. J Leukoc Biol 81: 212-220, 2007
4. Laudes IJ, Chu JC, Huber-Lang M, Guo RF, Riedemann NC, Sarma JV, Mahdi F, Murphy HS, Speyer C, Lu KT, Lambris JD, Zetoune FS, Ward PA: Expression and function of C5a receptor in mouse microvascular endothelial cells. J Immunol 169: 5962-5970, 2002
5. Riedemann NC, Guo RF, Sarma VJ, Laudes IJ, Huber-Lang M, Warner RL, Albrecht EA, Speyer CL, Ward PA: Expression and function of the C5a receptor in rat alveolar epithelial cells. J Immunol 168: 1919-1925, 2002
6. Drouin SM, Kildsgaard J, Haviland J, Zabner J, Jia HP, McCray PB Jr, Tack BF, Wetsel RA: Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. J Immunol 166: 2025-2032, 2001
7. Braun M, Davis AE 3rd: Cultured human glomerular mesangial cells express the C5a receptor. Kidney Int 54: 1542-1549, 1998
8. Shushakova N, Tkachuk N, Dangers M, Tkachuk S, Park JK, Hashimoto K, Haller H, Dumler I: Urokinase-induced activation of the gp130/Tyk2/Stat3 pathway mediates a pro-inflammatory effect in human mesangial cells via expression of the anaphylatoxin C5a receptor. J Cell Sci 118: 2743-2753, 2005
9. Fayyazi A, Scheel O, Werfel T, Schweyer S, Oppermann M, Gotze O, Radzun HJ, Zwirner J: The C5a receptor is expressed in normal renal proximal tubular but not in normal pulmonary or hepatic epithelial cells. Immunology 99: 38-45, 2000
10. Pratt JR, Hibbs MJ, Laver AJ, Smith RA, Sacks SH: Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat. Am J Pathol 149: 2055-2066, 1996
11. Pratt JR, Basheer SA, Sacks SH: Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 8: 582-587, 2002
12. Wang H, Jiang J, Liu W, Kubelik D, Chen G, Gies D, Garcia B, Zhong R, Rother RP: Prevention of acute vascular rejection by a functionally blocking anti-C5 monoclonal antibody combined with cyclosporine. Transplantation 79: 1121-1127, 2005
13. Keshavjee S, Davis RD, Zamora MR, de Perrot M, Patterson GA: A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings. J Thorac Cardiovasc Surg 129: 423-428, 2005
14. Arumugam TV, Shiels IA, Woodruff TM, Granger DN, Taylor SM: The role of the complement system in ischemia-reperfusion injury. Shock 21: 401-409, 2004
15. Woodruff TM, Arumugam TV, Shiels IA, Reid RC, Fairlie DP, Taylor SM: Protective effects of a potent C5a receptor antagonist on experimental acute limb ischemia-reperfusion in rats. J Surg Res 116: 81-90, 2004
16. Zhang H, Qin G, Liang G, Li J, Barrington RA, Liu DX: C5aR-mediated myocardial ischemia/reperfusion injury. Biochem Biophys Res Commun 357: 446-452, 2007
17. Arumugam TV, Shiels IA, Strachan AJ, Abbenante G, Fairlie DP, Taylor SM: A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats. Kidney Int 63: 134-142, 2003
18. de Vries B, Kohl J, Leclercq WK, Wolfs TG, van Bijnen AA, Heeringa P, Buurman WA: Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J Immunol 170: 3883-3889, 2003
19. Mengel M, Bogers J, Bosmans JL, Seron D, Moreso F, Carrera M, Gwinner W, Schwarz A, De Broe M, Kreipe H, Haller H: Incidence of C4d stain in protocol biopsies from renal allografts: Results from a multicenter trial. Am J Transplant 5: 1050-1056, 2005
20. El-Sawy T, Belperio JA, Strieter RM, Remick DG, Fairchild RL: Inhibition of polymorphonuclear leukocyte-mediated graft damage synergizes with short-term costimulatory blockade to prevent cardiac allograft rejection. Circulation 112: 320-331, 2005
21. De Vries B, Matthijsen RA, Wolfs TG, Van Bijnen AA, Heeringa P, Buurman WA: Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: Inhibition of late apoptosis and inflammation. Transplantation 75: 375-382, 2003
22. Meldrum KK, Metcalfe P, Leslie JA, Misseri R, Hile KL, Meldrum DR: TNF-alpha neutralization decreases nuclear factor-kappaB activation and apoptosis during renal obstruction. J Surg Res 131: 182-188, 2006
23. Wong M, Ziring D, Korin Y, Desai S, Kim S, Lin J, Gjertson D, Braun J, Reed E, Singh RR: TNFalpha blockade in human diseases: Mechanisms and future directions. Clin Immunol 126: 121-136, 2008
24. Donnahoo KK, Shames BD, Harken AH, Meldrum DR: Review article: The role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol 162: 196-203, 1999
25. Gueler F, Rong S, Park JK, Fiebeler A, Menne J, Elger M, Mueller DN, Hampich F, Dechend R, Kunter U, Luft FC, Haller H: Postischemic acute renal failure is reduced by short-term statin treatment in a rat model. J Am Soc Nephrol 13: 2288-2298, 2002
26. Perez de Lema G, Maier H, Nieto E, Vielhauer V, Luckow B, Mampaso F, Schlondorff D: Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol 12: 1369-1382, 2001
27. Wenzel U, Schneider A, Valente AJ, Abboud HE, Thaiss F, Helmchen UM, Stahl RA: Monocyte chemoattractant protein-1 mediates monocyte/macrophage influx in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int 51: 770-776, 1997
28. Albrecht EA, Chinnaiyan AM, Varambally S, Kumar-Sinha C, Barrette TR, Sarma JV, Ward PA: C5a-induced gene expression in human umbilical vein endothelial cells. Am J Pathol 164: 849-859, 2004
29. Skokowa J, Ali SR, Felda O, Kumar V, Konrad S, Shushakova N, Schmidt RE, Piekorz RP, Nurnberg B, Spicher K, Birnbaumer L, Zwirner J, Claassens JW, Verbeek JS, van Rooijen N, Kohl J, Gessner JE: Macrophages induce the inflammatory response in the pulmonary arthus reaction through Galphai2 activation that controls C5aR and Fc receptor cooperation. J Immunol 174: 3041-3050, 2005
30. Nakashima S, Qian Z, Rahimi S, Wasowska BA, Baldwin WM 3rd: Membrane attack complex contributes to destruction of vascular integrity in acute lung allograft rejection. J Immunol 169: 4620-4627, 2002
31. Nicholas SB, Aguiniga E, Ren Y, Kim J, Wong J, Govindarajan N, Noda M, Wang W, Kawano Y, Collins A, Hsueh WA: Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy. Kidney Int 67: 1297-1307, 2005
32. Muller TF, Kraus M, Neumann C, Lange H: Detection of renal allograft rejection by complement components C5A and TCC in plasma and urine. J Lab Clin Med 129: 62-71, 1997
33. Perianayagam MC, Balakrishnan VS, Pereira BJ, Jaber BL: C5a delays apoptosis of human neutrophils via an extracellular signal-regulated kinase and Bad-mediated signalling pathway. Eur J Clin Invest 34: 50-56, 2004
34. Perianayagam MC, Balakrishnan VS, King AJ, Pereira BJ, Jaber BL: C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway. Kidney Int 61: 456-463, 2002
35. Guo RF, Sun L, Gao H, Shi KX, Rittirsch D, Sarma VJ, Zetoune FS, Ward PA: In vivo regulation of neutrophil apoptosis by C5a during sepsis. J Leukoc Biol 80: 1575-1583, 2006
36. Guo RF, Huber-Lang M, Wang X, Sarma V, Padgaonkar VA, Craig RA, Riedemann NC, McClintock SD, Hlaing T, Shi MM, Ward PA: Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis. J Clin Invest 106: 1271-1280, 2000
37. Sund S, Reisaeter AV, Scott H, Mollnes TE, Hovig T: Glomerular monocyte/macrophage influx correlates strongly with complement activation in 1-week protocol kidney allograft biopsies. Clin Nephrol 62: 121-130, 2004
38. Srinivas TR, Kubilis PS, Croker BP: Macrophage index predicts short-term renal allograft function and graft survival. Transpl Int 17: 195-201, 2004
39. Jose MD, Ikezumi Y, van Rooijen N, Atkins RC, Chadban SJ: Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation 76: 1015-1022, 2003
40. Segerer S, Nelson PJ, Schlondorff D: Chemokines, chemokine receptors, and renal disease: From basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 11: 152-176, 2000
41. Bao L, Osawe I, Puri T, Lambris JD, Haas M, Quigg RJ: C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist. Eur J Immunol 35: 2496-2506, 2005
42. Li K, Sacks SH, Zhou W: The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies. Mol Immunol 44: 3866-3874, 2007
43. Zhou W, Peng Q, Li K, Sacks SH: Role of dendritic cell synthesis of complement in the allospecific T cell response. Mol Immunol 44: 57-63, 2007
44. Wenderfer SE, Ke B, Hollmann TJ, Wetsel RA, Lan HY, Braun MC: C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice. J Am Soc Nephrol 16: 3572-3582, 2005
45. Kohl J, Baelder R, Lewkowich IP, Pandey MK, Hawlisch H, Wang L, Best J, Herman NS, Sproles AA, Zwirner J, Whitsett JA, Gerard C, Sfyroera G, Lambris JD, Wills-Karp M: A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. J Clin Invest 116: 783-796, 2006
46. Kohl J, Wills-Karp M: Complement regulates inhalation tolerance at the dendritic cell/T cell interface. Mol Immunol 44: 44-56, 2007
47. Wills-Karp M: Complement activation pathways: A bridge between innate and adaptive immune responses in asthma. Proc Am Thorac Soc 4: 247-251, 2007
48. Wills-Karp M, Koehl J: New insights into the role of the complement pathway in allergy and asthma. Curr Allergy Asthma Rep 5: 362-369, 2005
49. Lalli PN, Strainic MG, Lin F, Medof ME, Heeger PS: Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production. J Immunol 179: 5793-5802, 2007
50. Heeger PS, Lalli PN, Lin F, Valujskikh A, Liu J, Muqim N, Xu Y, Medof ME: Decay-accelerating factor modulates induction of T cell immunity. J Exp Med 201: 1523-1530, 2005
51. Racusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM, Cecka MJ, Cosyns JP, Demetris AJ, Fishbein MC, Fogo A, Furness P, Gibson IW, Glotz D, Hayry P, Hunsickern L, Kashgarian M, Kerman R, Magil AJ, Montgomery R, Morozumi K, Nickeleit V, Randhawa P, Regele H, Seron D, Seshan S, Sund S, Trpkov K: Antibody-mediated rejection criteria: An addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 3: 708-714, 2003
52. Schnatbaum K, Locardi E, Scharn D, Richter U, Hawlisch H, Knolle J, Polakowski T: Peptidomimetic C5a receptor antagonists with hydrophobic substitutions at the C-terminus: Increased receptor specificity and in vivo activity. Bioorg Med Chem Lett 16: 5088-5092, 2006
53. Boor P, Konieczny A, Villa L, Schult AL, Bucher E, Rong S, Kunter U, van Roeyen CR, Polakowski T, Hawlisch H, Hillebrandt S, Lammert F, Eitner F, Floege J, Ostendorf T: Complement C5 mediates experimental tubulointerstitial fibrosis. J Am Soc Nephrol 18: 1508-1515, 2007
54. Ziegler E, Gueler F, Rong S, Mengel M, Witzke O, Kribben A, Haller H, Kunzendorf U, Krautwald S: CCL19-IgG prevents allograft rejection by impairment of immune cell trafficking. J Am Soc Nephrol 17: 2521-2532, 2006
55. Racusen LC: The Banff schema and differential diagnosis of allograft dysfunction. Transplant Proc 36: 753-754, 2004
56. Muller PY, Janovjak H, Miserez AR, Dobbie Z: Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32: 1372-1374, 1376, 1378-1379, 2002
57. Kreisel D, Krupnick AS, Szeto WY, Popma SH, Sankaran D, Krasinskas AM, Amin KM, Rosengard BR: A simple method for culturing mouse vascular endothelium. J Immunol Methods 254: 31-45, 2001
58. Hubbard AK, Giardina C: Regulation of ICAM-1 expression in mouse macrophages. Inflammation 24: 115-125, 2000